{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:16:57Z","timestamp":1790011017480,"version":"4.0.1"},"reference-count":219,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.pharmthera.2021.108030","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T12:00:34Z","timestamp":1635940834000},"page":"108030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Impact of drug treatment and drug interactions in post-stroke epilepsy"],"prefix":"10.1016","volume":"233","author":[{"given":"Lanqing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reetta","family":"K\u00e4lvi\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Jolkkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuansheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2021.108030_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.seizure.2021.04.011","article-title":"Acute symptomatic seizures and epilepsy after mechanical thrombectomy. A prospective long-term follow-up study","volume":"89","author":"Alemany","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0010","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/1940-6207.CAPR-11-0536","article-title":"Metformin reduces endogenous reactive oxygen species and associated DNA damage","volume":"5","author":"Algire","year":"2012","journal-title":"Cancer Prevention Research (Philadelphia, Pa.)"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00415-012-6583-6","article-title":"Acute seizures in acute ischemic stroke: Does thrombolysis have a role to play?","volume":"260","author":"Alvarez","year":"2013","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0020","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1212\/01.WNL.0000038388.57824.B6","article-title":"Gabapentin in late-onset poststroke seizures","volume":"59","author":"Alvarez-Sab\u00edn","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1528-1157.2001.11300.x","article-title":"Enhanced calcium influx in hippocampal CA3 neurons of spontaneously epileptic rats","volume":"42","author":"Amano","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuroscience.2013.10.060","article-title":"Tissue-type plasminogen activator mediates neuroglial coupling in the central nervous system","volume":"257","author":"An","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0035","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00228-019-02703-3","article-title":"The effect of simvastatin on warfarin anticoagulation: A Swedish register-based nationwide cohort study","volume":"75","author":"Andersson","year":"2019","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0040","doi-asserted-by":"crossref","first-page":"104898","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104898","article-title":"The role of hemorrhagic transformation in acute ischemic stroke upon clinical complications and outcomes","volume":"29","author":"Andrade","year":"2020","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1677\/JOE-08-0278","article-title":"Metformin induces oxidative stress in white adipocytes and raises uncoupling protein 2 levels","volume":"199","author":"Anedda","year":"2008","journal-title":"The Journal of Endocrinology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.lfs.2017.12.006","article-title":"Losartan suppresses the kainate-induced changes of angiotensin AT(1) receptor expression in a model of comorbid hypertension and epilepsy","volume":"193","author":"Atanasova","year":"2018","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0055","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1212\/WNL.41.5.740","article-title":"Interactions between calcium channel blockers and the anticonvulsants carbamazepine and phenytoin","volume":"41","author":"Bahls","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0060","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.pharep.2017.05.005","article-title":"Sotalol enhances the anticonvulsant action of valproate and diphenylhydantoin in the mouse maximal electroshock model","volume":"69","author":"Banach","year":"2017","journal-title":"Pharmacological Reports"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.seizure.2018.06.002","article-title":"The quality of life of older adults with epilepsy: A systematic review","volume":"60","author":"Baranowski","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0070","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/ana.24147","article-title":"Losartan prevents acquired epilepsy via TGF-\u03b2 signaling suppression","volume":"75","author":"Bar-Klein","year":"2014","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0075","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/08830738050200030901","article-title":"Epilepsy in shunted posthemorrhagic infantile hydrocephalus owing to pre- or perinatal intra- or periventricular hemorrhage","volume":"20","author":"Battaglia","year":"2005","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0080","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1528-1167.2009.02285.x","article-title":"Recommendation for a definition of acute symptomatic seizure","volume":"51","author":"Beghi","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0085","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1212\/WNL.0b013e3182364878","article-title":"Incidence and predictors of acute symptomatic seizures after stroke","volume":"77","author":"Beghi","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0090","doi-asserted-by":"crossref","first-page":"106476","DOI":"10.1016\/j.yebeh.2019.106476","article-title":"Incidence of early poststroke seizures during reperfusion therapies in patients with acute ischemic stroke: An observational prospective study: (TESI study: \u201cTrombolisi\/Trombectomia e crisi Epilettiche precoci nello Stroke Ischemico\u201d)","volume":"104","author":"Belcastro","year":"2020","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0095","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/ene.13292","article-title":"Epileptic manifestations in stroke patients treated with intravenous alteplase","volume":"24","author":"Bentes","year":"2017","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0100","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.pharep.2014.03.009","article-title":"Antiarrhythmic drugs and epilepsy","volume":"66","author":"Borowicz","year":"2014","journal-title":"Pharmacological Reports"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0105","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1471-4159.2004.02980.x","article-title":"Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones","volume":"92","author":"B\u00f6sel","year":"2005","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0110","doi-asserted-by":"crossref","first-page":"106312","DOI":"10.1016\/j.yebeh.2019.04.056","article-title":"Intravenous thrombolysis with tPA and cortical involvement increase the risk of early poststroke seizures: Results of a case-control study","volume":"104","author":"Brigo","year":"2020","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0115","doi-asserted-by":"crossref","first-page":"106353","DOI":"10.1016\/j.yebeh.2019.05.048","article-title":"Early poststroke seizures following thrombolysis and\/or thrombectomy for acute stroke: Clinical and stroke characteristics","volume":"104","author":"Brigo","year":"2020","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0120","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3389\/fneur.2019.01256","article-title":"Risk factors for epilepsy after thrombolysis for ischemic stroke: A cohort study","volume":"10","author":"Brondani","year":"2019","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0125","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1528-1167.2011.03118.x","article-title":"Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers","volume":"52","author":"Bullman","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0130","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1136\/bmj.315.7122.1582","article-title":"Epileptic seizures after a first stroke: The Oxfordshire community stroke project","volume":"315","author":"Burn","year":"1997","journal-title":"Bmj"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0135","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.1212\/WNL.0000000000007895","article-title":"The risk of new-onset epilepsy and refractory epilepsy in older adult stroke survivors","volume":"93","author":"Burneo","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archneurol.2011.1175","article-title":"Brain excitability in stroke: The yin and yang of stroke progression","volume":"69","author":"Carmichael","year":"2012","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0145","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000223361.90278.ca","article-title":"Continuous assessment of electrical epileptic activity in acute stroke","volume":"67","author":"Carrera","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0150","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/jama.2017.13883","article-title":"Association between use of non-vitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation","volume":"318","author":"Chang","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0155","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1152\/jn.2002.87.6.2851","article-title":"Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity","volume":"87","author":"Chen","year":"2002","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2202-10-7","article-title":"Atorvastatin ameliorates cerebral vasospasm and early brain injury after subarachnoid hemorrhage and inhibits caspase-dependent apoptosis pathway","volume":"10","author":"Cheng","year":"2009","journal-title":"BMC Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0165","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/epi.12686","article-title":"Protective effects of some statins on epileptogenesis and depressive-like behavior in WAG\/Rij rats, a genetic animal model of absence epilepsy","volume":"55","author":"Citraro","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0170","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s00415-017-8573-1","article-title":"Mortality after primary intracerebral hemorrhage in relation to post-stroke seizures","volume":"264","author":"Claessens","year":"2017","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0175","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s11064-005-6878-4","article-title":"Lipid signaling in experimental epilepsy","volume":"30","author":"Cole-Edwards","year":"2005","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0180","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000342669","article-title":"Levetiracetam versus carbamazepine in patients with late poststroke seizures: A multicenter prospective randomized open-label study (EpIC project)","volume":"34","author":"Consoli","year":"2012","journal-title":"Cerebrovascular Diseases"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0185","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1523\/JNEUROSCI.2544-04.2005","article-title":"3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate beta-amyloid-induced microglial inflammatory responses","volume":"25","author":"Cordle","year":"2005","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0190","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12028-011-9657-x","article-title":"Subacute seizure incidence in thrombolysis-treated ischemic stroke patients","volume":"16","author":"Couillard","year":"2012","journal-title":"Neurocritical Care"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0195","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/01616412.2018.1447318","article-title":"Pitavastatin treatment induces neuroprotection through the BDNF-TrkB signalling pathway in cultured cerebral neurons after oxygen-glucose deprivation","volume":"40","author":"Cui","year":"2018","journal-title":"Neurological Research"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2021.108030_bb0200","article-title":"Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE)","volume":"28","author":"Cushman","year":"1989","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0205","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/brain\/awu350","article-title":"Predicting novel histopathological microlesions in human epileptic brain through transcriptional clustering","volume":"138","author":"Dachet","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0210","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s40265-018-0947-x","article-title":"Assessment of the risk of rhabdomyolysis and myopathy during concomitant treatment with ticagrelor and statins","volume":"78","author":"Danielak","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0215","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pediatrneurol.2018.04.009","article-title":"Hypothesis: Presymptomatic treatment of sturge-weber syndrome with aspirin and antiepileptic drugs may delay seizure onset","volume":"90","author":"Day","year":"2019","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0220","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1755-5949.2008.00057.x","article-title":"Ang II and Ang IV: Unraveling the mechanism of action on synaptic plasticity, memory, and epilepsy","volume":"14","author":"De Bundel","year":"2008","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0225","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.clineuro.2010.01.004","article-title":"Acute ischemic stroke treatment and the occurrence of seizures","volume":"112","author":"De Reuck","year":"2010","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0230","doi-asserted-by":"crossref","first-page":"9.37.1","DOI":"10.1002\/0471142301.ns0937s58","article-title":"Pentylenetetrazol (PTZ) kindling model of epilepsy","volume":"58","author":"Dhir","year":"2012","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.pharmthera.2021.108030_bb0235","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11910-019-0957-4","article-title":"Incidence, implications, and management of seizures following ischemic and hemorrhagic stroke","volume":"19","author":"Doria","year":"2019","journal-title":"Current Neurology and Neuroscience Reports"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0240","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1073\/pnas.95.15.8880","article-title":"Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase","volume":"95","author":"Endres","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0245","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/bcp.14428","article-title":"Drug-drug interaction between warfarin and statins: A Danish cohort study","volume":"87","author":"Engell","year":"2021","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0250","doi-asserted-by":"crossref","first-page":"106520","DOI":"10.1016\/j.yebeh.2019.106520","article-title":"Acute symptomatic seizures and epilepsy after mechanical thrombectomy","volume":"104","author":"Eriksson","year":"2020","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0255","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0014-2999(80)90419-7","article-title":"Captopril given intracerebroventricularly, subcutaneously or by gavage inhibits angiotensin-converting enzyme activity in the rat brain","volume":"68","author":"Evered","year":"1980","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0260","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jocn.2020.11.023","article-title":"Statin on post-stroke epilepsy: A systematic review and meta-analysis","volume":"83","author":"Fang","year":"2021","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0265","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/10641960600549215","article-title":"Early poststroke seizures","volume":"28","author":"Feleppa","year":"2006","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0270","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/epi.13448","article-title":"Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors","volume":"57","author":"Ferlazzo","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0275","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: A practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0280","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizures and epilepsy: Definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0285","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/clpt.2011.295","article-title":"A screening study of drug-drug interactions in cerivastatin users: An adverse effect of clopidogrel","volume":"91","author":"Floyd","year":"2012","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0290","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1468-1331.2010.03241.x","article-title":"Diagnostic difficulties in the classification of transient neurological attacks","volume":"18","author":"Fonseca","year":"2011","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0295","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3389\/fneur.2018.01067","article-title":"Pharmacokinetic interactions of clinical interest between direct oral anticoagulants and antiepileptic drugs","volume":"9","author":"Galgani","year":"2018","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0300","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1474-4422(18)30075-9","article-title":"The SeLECT score is useful to predict post-stroke epilepsy","volume":"17","author":"Galovic","year":"2018","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0305","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40266-021-00837-7","article-title":"Seizures and epilepsy after stroke: Epidemiology, biomarkers and management","volume":"38","author":"Galovic","year":"2021","journal-title":"Drugs & Aging"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0310","doi-asserted-by":"crossref","first-page":"106540","DOI":"10.1016\/j.yebeh.2019.106540","article-title":"Younger age at stroke onset but not thrombolytic treatment predicts poststroke epilepsy: An updated meta-analysis","volume":"104","author":"Gasparini","year":"2020","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0315","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s10072-019-03913-4","article-title":"Hypertension, seizures, and epilepsy: A review on pathophysiology and management","volume":"40","author":"Gasparini","year":"2019","journal-title":"Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0320","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/WNF.0b013e3180333069","article-title":"Monotherapy of lamotrigine versus carbamazepine in patients with poststroke seizure","volume":"30","author":"Gilad","year":"2007","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0325","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.yebeh.2012.12.031","article-title":"Does aspirin use make it harder to collect seizures during elective video-EEG telemetry?","volume":"27","author":"Godfred","year":"2013","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0330","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1212\/WNL.45.5.865","article-title":"Common drugs may influence motor recovery after stroke. The Sygen in acute stroke study investigators","volume":"45","author":"Goldstein","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0335","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neuint.2012.04.012","article-title":"The levels of renin-angiotensin related components are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy","volume":"61","author":"Gouveia","year":"2012","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0340","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/STROKEAHA.111.000220","article-title":"Incidence and associations of poststroke epilepsy: The prospective South London stroke register","volume":"44","author":"Graham","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0345","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1111\/febs.12546","article-title":"miRNA expression is modulated over time after focal ischaemia: Up-regulation of miR-347 promotes neuronal apoptosis","volume":"280","author":"Gubern","year":"2013","journal-title":"The FEBS Journal"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0350","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1212\/WNL.0000000000001814","article-title":"Statin treatment reduces the risk of poststroke seizures","volume":"85","author":"Guo","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0355","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: An emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"Bmj"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0360","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.eplepsyres.2009.04.003","article-title":"Levetiracetam-induced platelet dysfunction","volume":"86","author":"Hacquard","year":"2009","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0365","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jstrokecerebrovasdis.2007.07.007","article-title":"Reperfusion seizures: A manifestation of cerebral reperfusion injury after administration of recombinant tissue plasminogen activator for acute ischemic stroke","volume":"16","author":"Hafeez","year":"2007","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0370","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1160\/TH09-08-0516","article-title":"The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response","volume":"103","author":"Harmsze","year":"2010","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0375","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.brainres.2004.12.051","article-title":"HMG CoA reductase inhibitors reduce ischemic brain injury of Wistar rats through decreasing oxidative stress on neurons","volume":"1037","author":"Hayashi","year":"2005","journal-title":"Brain Research"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2021.108030_bb0380","first-page":"S173","article-title":"Neurotransmitter-mediated mechanisms of traumatic brain injury: Acetylcholine and excitatory amino acids","volume":"9","author":"Hayes","year":"1992","journal-title":"Journal of Neurotrauma"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0385","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1528-1167.2008.01945.x","article-title":"Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure","volume":"50","author":"Hesdorffer","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0390","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1528-1157.1996.tb00644.x","article-title":"Severe, uncontrolled hypertension and adult-onset seizures: A case-control study in Rochester, Minnesota","volume":"37","author":"Hesdorffer","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0395","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.1136","article-title":"Are certain diuretics also anticonvulsants?","volume":"50","author":"Hesdorffer","year":"2001","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0400","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4045\/tidsskr.12.1344","article-title":"The role of glial cells in epilepsy","volume":"134","author":"Heuser","year":"2014","journal-title":"Tidsskrift for den Norske L\u00e6geforening"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0405","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1055\/s-0037-1613486","article-title":"The effect of simvastatin co-medication on warfarin anticoagulation response and dose requirements","volume":"89","author":"Hickmott","year":"2003","journal-title":"Thrombosis and Haemostasis"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2021.108030_bb0410","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1528-1167.2012.03471.x","article-title":"The extracellular space and epileptic activity in the adult brain: Explaining the antiepileptic effects of furosemide and bumetanide","volume":"53","author":"Hochman","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0415","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/2396987317705536","article-title":"European stroke organisation guidelines for the management of post-stroke seizures and epilepsy","volume":"2","author":"Holtkamp","year":"2017","journal-title":"European Stroke Journal"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0420","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/STROKEAHA.113.004015","article-title":"Early-onset seizures are correlated with late-onset seizures in children with arterial ischemic stroke","volume":"45","author":"Hsu","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0425","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.neuint.2013.01.017","article-title":"Glial cell changes in epilepsy: Overview of the clinical problem and therapeutic opportunities","volume":"63","author":"Hubbard","year":"2013","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0430","first-page":"1997","article-title":"Epilepsy after aneurysmal subarachnoid hemorrhage: A population-based, long-term follow-up study","volume":"85","author":"Huttunen","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0435","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/npp.2012.134","article-title":"Epigenetic mechanisms in stroke and epilepsy","volume":"38","author":"Hwang","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0440","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/0028-3908(95)00146-8","article-title":"Effect of chronic treatment with trandolapril or enalapril on brain ACE activity in spontaneously hypertensive rats","volume":"34","author":"Jouquey","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0445","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/clpt.2011.163","article-title":"Prolonged use of aspirin alters human and rat intestinal cells and thereby limits the absorption of clopidogrel","volume":"90","author":"Jung","year":"2011","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0450","doi-asserted-by":"crossref","first-page":"13012","DOI":"10.1523\/JNEUROSCI.3605-07.2007","article-title":"Progressive dendritic HCN channelopathy during epileptogenesis in the rat pilocarpine model of epilepsy","volume":"27","author":"Jung","year":"2007","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0455","doi-asserted-by":"crossref","first-page":"14291","DOI":"10.1523\/JNEUROSCI.1148-11.2011","article-title":"Rapid loss of dendritic HCN channel expression in hippocampal pyramidal neurons following status epilepticus","volume":"31","author":"Jung","year":"2011","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0460","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.yebeh.2010.05.006","article-title":"Functional integration of new neurons into hippocampal networks and poststroke comorbidities following neonatal stroke in mice","volume":"18","author":"Kadam","year":"2010","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0465","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0091-3057(01)00468-3","article-title":"Amlodipine enhances the activity of antiepileptic drugs against pentylenetetrazole-induced seizures","volume":"68","author":"Kami\u0144ski","year":"2001","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0470","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0009-9236(98)90151-5","article-title":"Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations","volume":"64","author":"Kantola","year":"1998","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0475","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s11064-005-8831-y","article-title":"Epileptogenesis after experimental focal cerebral ischemia","volume":"30","author":"Karhunen","year":"2005","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0480","doi-asserted-by":"crossref","first-page":"337","DOI":"10.12691\/ajmcr-7-12-9","article-title":"Ticagrelor and statin interaction induces rhabdomyolysis and acute renal failure: Case reports and scoping review","volume":"7","author":"Kariyanna","year":"2019","journal-title":"Am J Med Case Rep"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0485","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1007\/s00415-015-7850-0","article-title":"Does treatment with t-PA increase the risk of developing epilepsy after stroke?","volume":"262","author":"Keller","year":"2015","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0490","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2008.02.070","article-title":"Expression of GABA A receptor alpha1 subunit mRNA and protein in rat neocortex following photothrombotic infarction","volume":"1210","author":"Kharlamov","year":"2008","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0495","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s12325-020-01592-8","article-title":"Pharmacokinetic interaction between telmisartan and rosuvastatin\/ezetimibe after multiple oral administration in healthy subjects","volume":"38","author":"Kim","year":"2021","journal-title":"Advances in Therapy"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0500","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/NMD.0b013e318093f425","article-title":"Novelty-seeking among schizophrenia patients with comorbid alcohol abuse","volume":"195","author":"Kim","year":"2007","journal-title":"The Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0505","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1528-1157.1999.tb00709.x","article-title":"Valproate treatment and platelet function: The role of arachidonate metabolites","volume":"40","author":"Kis","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0510","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/clpt.2014.183","article-title":"Clopidogrel bioactivation and risk of bleeding in patients cotreated with angiotensin-converting enzyme inhibitors after myocardial infarction: A proof-of-concept study","volume":"96","author":"Kristensen","year":"2014","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0515","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1161\/STROKEAHA.114.006974","article-title":"Early onset seizures in stroke","volume":"45","author":"Kulhari","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0520","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1179\/1743132812Y.0000000127","article-title":"Atorvastatin and pitavastatin reduce oxidative stress and improve IR\/LDL-R signals in Alzheimer\u2019s disease","volume":"35","author":"Kurata","year":"2013","journal-title":"Neurological Research"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0525","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.yebeh.2008.04.025","article-title":"Levetiracetam monotherapy for late poststroke seizures in the elderly","volume":"13","author":"Kutlu","year":"2008","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0530","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1212\/WNL.57.2.200","article-title":"Prevalence and predictors of early seizure and status epilepticus after first stroke","volume":"57","author":"Labovitz","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0535","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1212\/WNL.0000000000004009","article-title":"Poststroke epilepsy in long-term survivors of primary intracerebral hemorrhage","volume":"88","author":"Lahti","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0540","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/WNL.60.3.400","article-title":"Early and late seizures after cryptogenic ischemic stroke in young adults","volume":"60","author":"Lamy","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0545","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.0000047060.60595.CC","article-title":"Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: A new drug-drug interaction","volume":"107","author":"Lau","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0550","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1161\/01.STR.31.10.2442","article-title":"Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice","volume":"31","author":"Laufs","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0555","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3171\/jns.1997.87.1.0073","article-title":"Seizures induced by intracerebral injection of thrombin: A model of intracerebral hemorrhage","volume":"87","author":"Lee","year":"1997","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0560","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1471-4159.2007.05044.x","article-title":"Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS\/c-Jun levels and activating ERK\/Akt pathways","volume":"104","author":"Lee","year":"2008","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0565","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/1747493017729239","article-title":"Incidence of seizure in stroke patients treated with recombinant tissue plasminogen activator: A systematic review and meta-analysis","volume":"12","author":"Lekoubou","year":"2017","journal-title":"International Journal of Stroke"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0570","doi-asserted-by":"crossref","first-page":"106472","DOI":"10.1016\/j.yebeh.2019.106472","article-title":"Modeling poststroke epilepsy and preclinical development of drugs for poststroke epilepsy","volume":"104","author":"Leo","year":"2020","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0575","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/jnnp-2015-311849","article-title":"The prognosis of acute symptomatic seizures after ischaemic stroke","volume":"88","author":"Leung","year":"2017","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0580","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1212\/WNL.0000000000003399","article-title":"Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke","volume":"87","author":"Leys","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0585","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.seizure.2019.07.010","article-title":"Efficacy of statin therapy in post-stroke seizure prophylaxis: Clues from an observational study of routine secondary prevention treatment","volume":"71","author":"Li","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0590","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40263-018-0501-0","article-title":"Effect of statin intensity on the risk of epilepsy after ischaemic stroke: Real-world evidence from population-based health claims","volume":"32","author":"Lin","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0595","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1111\/bcp.13626","article-title":"Statin use associated with lower risk of epilepsy after intracranial haemorrhage: A population-based cohort study","volume":"84","author":"Lin","year":"2018","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0600","first-page":"260","article-title":"Epileptic seizures in non-embolic cerebral infarction","volume":"92","author":"Louis","year":"1967","journal-title":"Transactions of the American Neurological Association"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0605","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/jnr.20218","article-title":"Microarray analysis of acute and delayed gene expression profile in rats after focal ischemic brain injury and reperfusion","volume":"77","author":"Lu","year":"2004","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0610","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pbb.2011.06.030","article-title":"Interactions between ACE inhibitors and classical antiepileptic drugs in the mouse maximal electroshock seizures","volume":"100","author":"\u0141ukawski","year":"2011","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0615","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00702-010-0455-y","article-title":"Captopril potentiates the anticonvulsant activity of carbamazepine and lamotrigine in the mouse maximal electroshock seizure model","volume":"117","author":"Lukawski","year":"2010","journal-title":"Journal of Neural Transmission (Vienna)"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0620","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejphar.2013.02.054","article-title":"Combined treatment with gabapentin and drugs affecting the renin-angiotensin system against electroconvulsions in mice","volume":"706","author":"Lukawski","year":"2013","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0630","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2017.11.037","article-title":"Interactions of aliskiren, a direct renin inhibitor, with antiepileptic drugs in the test of maximal electroshock in mice","volume":"819","author":"\u0141ukawski","year":"2018","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0635","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1734-1140(12)70770-3","article-title":"Effect of hydrochlorothiazide on the anticonvulsant action of antiepileptic drugs against maximal electroshock-induced seizures in mice","volume":"64","author":"\u0141ukawski","year":"2012","journal-title":"Pharmacological Reports"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0640","first-page":"672","article-title":"Effects of three calcium channel antagonists (amlodipine, diltiazem and verapamil) on the protective action of lamotrigine in the mouse maximal electroshock-induced seizure model","volume":"59","author":"Luszczki","year":"2007","journal-title":"Pharmacological Reports"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0645","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2362.2005.01522.x","article-title":"Not all statins interfere with clopidogrel during antiplatelet therapy","volume":"35","author":"Mach","year":"2005","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0650","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.nbd.2012.10.017","article-title":"Thrombin regulation of synaptic transmission: Implications for seizure onset","volume":"50","author":"Maggio","year":"2013","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0655","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1523\/JNEUROSCI.3665-07.2008","article-title":"Thrombin induces long-term potentiation of reactivity to afferent stimulation and facilitates epileptic seizures in rat hippocampal slices: Toward understanding the functional consequences of cerebrovascular insults","volume":"28","author":"Maggio","year":"2008","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0660","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2796.2009.02119.x","article-title":"Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment","volume":"266","author":"Malmstr\u00f6m","year":"2009","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0665","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.eplepsyres.2014.08.013","article-title":"Pharmacokinetic interactions between topiramate and pioglitazone and metformin","volume":"108","author":"Manitpisitkul","year":"2014","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0670","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s40261-013-0143-4","article-title":"An open-label drug-drug interaction study of the steady-state pharmacokinetics of topiramate and glyburide in patients with type 2 diabetes mellitus","volume":"33","author":"Manitpisitkul","year":"2013","journal-title":"Clinical Drug Investigation"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0675","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/ncomms3192","article-title":"Metformin improves healthspan and lifespan in mice","volume":"4","author":"Martin-Montalvo","year":"2013","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0680","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1038\/s41598-020-58652-w","article-title":"Statin treatment can reduce incidence of early seizure in acute ischemic stroke: A propensity score analysis","volume":"10","author":"Matsubara","year":"2020","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0685","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00540-021-02901-3","article-title":"Intraoperative hypotension and perioperative acute ischemic stroke in patients having major elective non-cardiovascular non-neurological surgery","volume":"35","author":"Mazzeffi","year":"2021","journal-title":"Journal of Anesthesia"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0690","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2009.08.007","article-title":"Ischaemic stroke in adults and epilepsy","volume":"87","author":"Menon","year":"2009","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0695","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/STROKEAHA.117.020178","article-title":"Population-based assessment of the long-term risk of seizures in survivors of stroke","volume":"49","author":"Merkler","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0700","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.eplepsyres.2018.02.001","article-title":"Effects of adjunctive eslicarbazepine acetate on serum lipids in patients with partial-onset seizures: Impact of concomitant statins and enzyme-inducing antiepileptic drugs","volume":"141","author":"Mintzer","year":"2018","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0705","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1042\/BST0371389","article-title":"Rapid dendritic and axonal responses to neuronal insults","volume":"37","author":"Mizielinska","year":"2009","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0710","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1472-8206.2012.01038.x","article-title":"Anticonvulsive effect of atorvastatin on pentylenetetrazole-induced seizures in mice: The role of nitric oxide pathway","volume":"27","author":"Moazzami","year":"2013","journal-title":"Fundamental & Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0715","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1067\/mcp.2000.104609","article-title":"The interaction of diltiazem with simvastatin","volume":"67","author":"Mousa","year":"2000","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0720","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/pgmj.2005.041426","article-title":"Post-stroke seizure and post-stroke epilepsy","volume":"82","author":"Myint","year":"2006","journal-title":"Postgraduate Medical Journal"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0725","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12883-018-1064-x","article-title":"Association between different acute stroke therapies and development of post stroke seizures","volume":"18","author":"Naylor","year":"2018","journal-title":"BMC Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0730","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.seizure.2018.09.001","article-title":"Estimation of seizures prevalence in ischemic strokes after thrombolytic therapy","volume":"62","author":"Nesselroth","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0735","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12111040","article-title":"Effects of carbamazepine and phenytoin on pharmacokinetics and pharmacodynamics of rivaroxaban","volume":"12","author":"Ngo","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0740","doi-asserted-by":"crossref","first-page":"107400","DOI":"10.1016\/j.yebeh.2020.107400","article-title":"Statins in primary prevention of poststroke seizures and epilepsy: A systematic review","volume":"112","author":"Nucera","year":"2020","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0745","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/clpt.2014.49","article-title":"Aspirin decreases systemic exposure to clopidogrel through modulation of P-glycoprotein but does not alter its antithrombotic activity","volume":"95","author":"Oh","year":"2014","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0750","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.yebeh.2017.10.021","article-title":"Effect of atorvastatin on behavioral alterations and neuroinflammation during epileptogenesis","volume":"78","author":"Oliveira","year":"2018","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0755","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neulet.2008.10.023","article-title":"Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington\u2019s disease","volume":"448","author":"Patassini","year":"2008","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0760","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1073\/pnas.0406454102","article-title":"Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors","volume":"102","author":"Pawlak","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0765","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1172\/JCI0215961","article-title":"Tissue plasminogen activator and seizures: A clot-buster\u2019s secret life","volume":"109","author":"Pawlak","year":"2002","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0770","first-page":"69","article-title":"The effects of chronic losartan pretreatment on restraint stress-induced changes in motor activity, nociception and pentylenetetrazol generalized seizures in rats","volume":"53","author":"Pechlivanova","year":"2011","journal-title":"Folia Med (Plovdiv)"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0775","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12640-009-9057-6","article-title":"Atorvastatin prevents hippocampal cell death due to quinolinic acid-induced seizures in mice by increasing Akt phosphorylation and glutamate uptake","volume":"16","author":"Piermartiri","year":"2009","journal-title":"Neurotoxicity Research"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0780","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijcard.2012.04.051","article-title":"Pharmacokinetic interactions between clopidogrel and rosuvastatin: Effects on vascular protection in subjects with coronary heart disease","volume":"158","author":"Pinheiro","year":"2012","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0785","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1474-4422(15)00248-3","article-title":"Development of epilepsy after ischaemic stroke","volume":"15","author":"Pitk\u00e4nen","year":"2016","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0790","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/STROKEAHA.107.498923","article-title":"Simvastatin reduces the association of NMDA receptors to lipid rafts: A cholesterol-mediated effect in neuroprotection","volume":"39","author":"Ponce","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0795","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000338374","article-title":"Seizures in acute stroke: Incidence, risk factors and prognosis","volume":"39","author":"Procaccianti","year":"2012","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0800","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s11011-017-9979-2","article-title":"Synergistic anticonvulsant effects of pregabalin and amlodipine on acute seizure model of epilepsy in mice","volume":"32","author":"Qureshi","year":"2017","journal-title":"Metabolic Brain Disease"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0805","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052121","article-title":"Spatial and temporal gene expression differences in core and periinfarct areas in experimental stroke: A microarray analysis","volume":"7","author":"Ramos-Cejudo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0810","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1023\/A:1015823315983","article-title":"Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors","volume":"9","author":"Ranadive","year":"1992","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0815","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1590\/S0004-282X2005000600013","article-title":"Lovastatin reduces neuronal cell death in hippocampal CA1 subfield after pilocarpine-induced status epilepticus: Preliminary results","volume":"63","author":"Rangel","year":"2005","journal-title":"Arquivos de Neuro-Psiquiatria"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0820","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.seizure.2020.01.009","article-title":"Long-term follow-up of post-stroke epilepsy after ischemic stroke: Room for improved epilepsy treatment","volume":"76","author":"Redfors","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0825","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0006-8993(00)02121-1","article-title":"Agents which block potassium-chloride cotransport prevent sound-triggered seizures in post-ischemic audiogenic seizure-prone rats","volume":"864","author":"Reid","year":"2000","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0830","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1100\/tsw.2009.141","article-title":"Statins in neurological disorders: Mechanisms and therapeutic value","volume":"9","author":"Reiss","year":"2009","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0835","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1212\/01.wnl.0000247231.25231.2e","article-title":"Seizures during stroke thrombolysis heralding dramatic neurologic recovery","volume":"67","author":"Rodan","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0840","first-page":"86","article-title":"Post-stroke epilepsy","volume":"78","author":"Rodr\u00edguez Lucci","year":"2018","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0845","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/ene.12157","article-title":"Young adult ischaemic stroke related acute symptomatic and late seizures: Risk factors","volume":"20","author":"Roivainen","year":"2013","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0850","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/ane.13230","article-title":"Lacosamide in patients with epilepsy of cerebrovascular etiology","volume":"141","author":"Rosenow","year":"2020","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0855","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2012.12.002","article-title":"Pharmacodynamic potentiation of antiepileptic drugs\u2019 effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA\/2 mice","volume":"70","author":"Russo","year":"2013","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0860","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.67.12_suppl_4.S3","article-title":"Optimizing therapy of seizures in stroke patients","volume":"67","author":"Ryvlin","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0865","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2010.10.001","article-title":"Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications","volume":"36","author":"Saavedra","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0870","doi-asserted-by":"crossref","first-page":"117138","DOI":"10.1016\/j.jns.2020.117138","article-title":"Prevalence and predictors of post-stroke epilepsy among Ghanaian stroke survivors","volume":"418","author":"Sarfo","year":"2020","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0875","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.phrs.2011.11.005","article-title":"Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA\/2 mice","volume":"65","author":"Sarro","year":"2012","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0880","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2174\/1389450116666150330114850","article-title":"Statins and epilepsy: Preclinical studies, clinical trials and statin-anticonvulsant drug interactions","volume":"16","author":"Scicchitano","year":"2015","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0885","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1212\/01.wnl.0000278070.30744.01","article-title":"Seizures during stroke thrombolysis heralding dramatic neurologic recovery","volume":"69","author":"Seeck","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0890","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuroscience.2014.10.014","article-title":"HMG-CoA reductase inhibitor rosuvastatin improves abnormal brain electrical activity via mechanisms involving eNOS","volume":"284","author":"Seker","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0895","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000382078","article-title":"Are early seizures predictive of epilepsy after a stroke? Results of a population-based study","volume":"45","author":"Serafini","year":"2015","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0900","doi-asserted-by":"crossref","first-page":"14850","DOI":"10.1523\/JNEUROSCI.3922-11.2011","article-title":"Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus","volume":"31","author":"Serrano","year":"2011","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0905","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1179\/1743132812Y.0000000080","article-title":"The involvement of nitric oxide in the anti-seizure effect of acute atorvastatin treatment in mice","volume":"34","author":"Shafaroodi","year":"2012","journal-title":"Neurological Research"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0910","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-2010-101179","article-title":"Statins as neuroprotectants: A comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death","volume":"23","author":"Sierra","year":"2011","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0915","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/archneur.59.2.195","article-title":"Poststroke seizures","volume":"59","author":"Silverman","year":"2002","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0920","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/0091270005278224","article-title":"Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics","volume":"45","author":"Simonson","year":"2005","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0925","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1212\/WNL.46.2.350","article-title":"Population-based study of seizure disorders after cerebral infarction","volume":"46","author":"So","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0930","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mcn.2015.02.014","article-title":"Angiotensin II and its receptor in activated microglia enhanced neuronal loss and cognitive impairment following pilocarpine-induced status epilepticus","volume":"65","author":"Sun","year":"2015","journal-title":"Molecular and Cellular Neurosciences"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0935","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fneur.2013.00069","article-title":"Hemorrhagic transformation: A review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke","volume":"4","author":"Sussman","year":"2013","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0940","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.seizure.2020.06.018","article-title":"Cardiogenic cerebral infarction in the parietal lobe predicts the development of post-stroke epilepsy","volume":"80","author":"Takase","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0945","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1111\/j.1528-1167.2012.03635.x","article-title":"Tissue plasminogen activator does not alter development of acquired epilepsy","volume":"53","author":"Tan","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0950","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuint.2017.02.002","article-title":"Post-stroke epilepsy","volume":"107","author":"Tanaka","year":"2017","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0955","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2125.1991.tb03908.x","article-title":"Differential effects of valproic acid and enzyme-inducing anticonvulsants on nimodipine pharmacokinetics in epileptic patients","volume":"32","author":"Tartara","year":"1991","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0960","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.pharep.2018.03.002","article-title":"Effects of low and high doses of acetylsalicylic acid on penicillin-induced epileptiform activity","volume":"70","author":"Tasdemir","year":"2018","journal-title":"Pharmacological Reports"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0965","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.yebeh.2015.03.021","article-title":"Effects of AT1 receptor antagonism on kainate-induced seizures and concomitant changes in hippocampal extracellular noradrenaline, serotonin, and dopamine levels in Wistar-Kyoto and spontaneously hypertensive rats","volume":"46","author":"Tchekalarova","year":"2015","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0970","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s10571-015-0278-3","article-title":"Long-term treatment with losartan attenuates seizure activity and neuronal damage without affecting behavioral changes in a model of co-morbid hypertension and epilepsy","volume":"36","author":"Tchekalarova","year":"2016","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0975","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/WCO.0000000000000067","article-title":"Antiepileptogenesis in humans: Disappointing clinical evidence and ways to move forward","volume":"27","author":"Trinka","year":"2014","journal-title":"Current Opinion in Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0980","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000512799","article-title":"Treatment with diazepam in acute stroke prevents poststroke seizures: A substudy of the EGASIS trial","volume":"50","author":"van Tuijl","year":"2021","journal-title":"Cerebrovascular Diseases"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0985","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00228-003-0700-5","article-title":"Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid","volume":"59","author":"Ucar","year":"2004","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0990","article-title":"Evaluation and comparison of anticonvulsant activity of telmisartan and olmesartan in experimentally induced animal models of epilepsy","volume":"8","author":"V, H. P","year":"2014","journal-title":"Journal of Clinical and Diagnostic Research"},{"key":"10.1016\/j.pharmthera.2021.108030_bb0995","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2165\/00023210-200115080-00002","article-title":"Do statins afford neuroprotection in patients with cerebral ischaemia and stroke?","volume":"15","author":"Vaughan","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1000","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.atherosclerosis.2015.10.005","article-title":"Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy","volume":"243","author":"Verdoia","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1005","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1212\/WNL.0000000000007778","article-title":"SUDEP in the North American SUDEP registry: The full spectrum of epilepsies","volume":"93","author":"Verducci","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1010","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1038\/npp.2012.152","article-title":"Candesartan, an angiotensin II AT\u2081-receptor blocker and PPAR-\u03b3 agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice","volume":"37","author":"Villapol","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1015","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s10072-020-04298-5","article-title":"The influence of statins on the risk of post-stroke epilepsy","volume":"41","author":"Vitturi","year":"2020","journal-title":"Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nbd.2015.02.029","article-title":"Albumin induces excitatory synaptogenesis through astrocytic TGF-\u03b2\/ALK5 signaling in a model of acquired epilepsy following blood-brain barrier dysfunction","volume":"78","author":"Weissberg","year":"2015","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144806","article-title":"Rosiglitazone suppresses in vitro seizures in hippocampal slice by inhibiting presynaptic glutamate release in a model of temporal lobe epilepsy","volume":"10","author":"Wong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1030","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3171\/JNS\/2008\/109\/10\/0691","article-title":"Increase in phosphorylation of Akt and its downstream signaling targets and suppression of apoptosis by simvastatin after traumatic brain injury","volume":"109","author":"Wu","year":"2008","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024966","article-title":"Administration of simvastatin after kainic acid-induced status epilepticus restrains chronic temporal lobe epilepsy","volume":"6","author":"Xie","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/tnsci-2016-0001","article-title":"Early predictors and prevention for post-stroke epilepsy: Changes in neurotransmitter levels","volume":"7","author":"Xie","year":"2016","journal-title":"Translational Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neulet.2009.03.063","article-title":"Angiotensin II inhibits GABAergic synaptic transmission in dorsolateral periaqueductal gray neurons","volume":"455","author":"Xing","year":"2009","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.seizure.2020.10.004","article-title":"Statin use and the risk of post-stroke seizures: A meta-analysis","volume":"83","author":"Xu","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1055","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2010.07.006","article-title":"Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer\u2019s disease","volume":"1352","author":"Yamada","year":"2010","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1060","article-title":"The ALDH2 rs671 polymorphism affects post-stroke epilepsy susceptibility and plasma 4-HNE levels","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1065","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbrc.2017.01.157","article-title":"Chronic metformin treatment facilitates seizure termination","volume":"484","author":"Yang","year":"2017","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1070","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1523\/JNEUROSCI.23-35-11104.2003","article-title":"3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity","volume":"23","author":"Zacco","year":"2003","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1075","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/1756285616654423","article-title":"Poststroke epilepsy: Update and future directions","volume":"9","author":"Zelano","year":"2016","journal-title":"Therapeutic Advances in Neurological Disorders"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1080","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2014.03.003","article-title":"Evidence for involvement of the CD40\/CD40L system in post-stroke epilepsy","volume":"567","author":"Zhang","year":"2014","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1085","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.eplepsyres.2014.09.030","article-title":"Risk factors for post-stroke seizures: A systematic review and meta-analysis","volume":"108","author":"Zhang","year":"2014","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1090","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbrc.2014.04.130","article-title":"Metformin protects against seizures, learning and memory impairments and oxidative damage induced by pentylenetetrazole-induced kindling in mice","volume":"448","author":"Zhao","year":"2014","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1095","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000023577","article-title":"Effects of atorvastatin and aspirin on post-stroke epilepsy and usage of levetiracetam","volume":"99","author":"Zhao","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.pharmthera.2021.108030_bb1100","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1080\/01616412.2017.1326657","article-title":"Aspirin attenuates spontaneous recurrent seizures in the chronically epileptic mice","volume":"39","author":"Zhu","year":"2017","journal-title":"Neurological Research"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821002321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821002321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:20:09Z","timestamp":1759011609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725821002321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":219,"alternative-id":["S0163725821002321"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108030","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of drug treatment and drug interactions in post-stroke epilepsy","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108030"}}